January 30, 2015 4:11 PM ET


Company Overview of Grifols Biologicals, Inc.

Company Overview

Grifols Biologicals, Inc. researches, develops and produces therapeutic proteins from human plasma. Grifols Biologicals’ plant in Los Angeles, California has a total production capacity of 1.5 million liters per year. The company was incorporated in 2003 and is based in Los Angeles, California. Grifols Biologicals, Inc. operates as a subsidiary of Grifols, S.A.

5555 Valley Boulevard

Los Angeles, CA 90032-3548

United States

Founded in 2003





Key Executives for Grifols Biologicals, Inc.

Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
ViaCyte, Inc. United States
CoDa Therapeutics, Inc. United States
Global Blood Therapeutics, Inc. United States
Plant Cell Technologies, Inc. United States
Chiragene United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Grifols Biologicals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.